300452SZSE

Announcement on Adjusting the Conversion Price of Convertible Bonds for the 2025 Annual Equity Distribution

✨ AI Summary

Anhui Shanhe Pharmaceutical Auxiliary Co., Ltd. announced an adjustment to the conversion price of its convertible bonds from RMB 13.30 to RMB 13.00 per share, effective June 10, 2026. This adjustment follows the approval of the 2025 annual profit distribution plan, which includes a cash dividend of RMB 3.0 per 10 shares. The company emphasizes the importance of protecting the rights of convertible bondholders.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Announcement on Adjusting the Conversion Price of Convertible Bonds for the 2025 Annual Equity Distribution

Special Reminder:

  1. Stock Code: 300452, Stock Abbreviation: Shanhe Pharmaceutical Auxiliary
  2. Bond Code: 123199, Bond Abbreviation: Shanhe Convertible Bonds
  3. Previous Conversion Price: RMB 13.30 per share
  4. Adjusted Conversion Price: RMB 13.00 per share
  5. Effective Date of Adjusted Conversion Price: June 10, 2026

I. Relevant Provisions on the Adjustment of the Conversion Price of "Shanhe Convertible Bonds"

With the approval of the China Securities Regulatory Commission (CSRC) under document No. [2023] 268, Anhui Shanhe Pharmaceutical Auxiliary Co., Ltd. (hereinafter referred to as "Shanhe Pharmaceutical Auxiliary" or "the Company") issued 3,200,000 convertible corporate bonds (hereinafter referred to as "Convertible Bonds") on June 12, 2023, to unspecified objects, with a face value of RMB 100 each, totaling RMB 320 million. The bonds were listed and traded on the Shenzhen Stock Exchange starting July 7, 2023, under the abbreviation "Shanhe Convertible Bonds" and bond code "123199".

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.